Research Antibodies Market

Summary Table: Global Market for Research Antibodies, by Application, Through 2028
Table 1: Most-Cited Antibodies and Their Suppliers, 2022
Table 2: Global Market for Research Antibodies, by Type of Antibody, Through 2028
Table 3: Clinically Therapeutic Monoclonal Antibodies
Table 4: Global Market for Primary Antibodies, by Region, Through 2028
Table 5: Secondary Antibody Selection
Table 6: Global Market for Secondary Antibodies, by Region, Through 2028
Table 7: Global Market for Research Antibodies, by Clonality, Through 2028
Table 8: Global Market for Polyclonal Antibodies, by Region, Through 2028
Table 9: Global Market for Monoclonal Antibodies, by Region, Through 2028
Table 10: Global Market for Recombinant Antibodies, by Region, Through 2028
Table 11: Global Market for Research Antibodies, by Major Reactivity, Through 2028
Table 12: Global Market for Anti-Human Antibodies, by Region, Through 2028
Table 13: Global Market for Anti-Mouse Antibodies, by Region, Through 2028
Table 14: Rat Antibodies with Different Isotypes.
Table 15: Global Market for Anti-Rat Antibodies, by Region, Through 2028
Table 16: Other Antibodies with Different Isotypes.
Table 17: Global Market for Other Research Antibodies, by Region, Through 2028
Table 18: Global Market for Research Antibodies, by Application, Through 2028
Table 19: Global Market for Western Blot Applications, by Region, Through 2028
Table 20: Global Market for Flow Cytometry Applications, by Region, Through 2028
Table 21: Global Market for Immunohistochemistry Applications, by Region, Through 2028
Table 22: Global Market for Multiplex Staining Applications, by Region, Through 2028
Table 23: Global Market for Low-Flexed Staining Applications, by Region, Through 2028
Table 24: Global Market for Immunocytochemistry Staining Applications, by Region, Through 2028
Table 25: Global Market for Immunofluorescent Applications, by Region, Through 2028
Table 26: Global Market for Immunoprecipitation Applications, by Region, Through 2028
Table 27: Global Market for ELISA Applications, by Region, Through 2028
Table 28: Global Market for Research Antibodies, by Host Species, Through 2028
Table 29: Global Market for Rabbit Research Antibodies, by Region, Through 2028
Table 30: Global Market for Goat Research Antibodies, by Region, Through 2028
Table 31: Global Market for Mouse Research Antibodies, by Region, Through 2028
Table 32: Global Market for Sheep Research Antibodies, by Region, Through 2028
Table 33: Global Market for Donkey Research Antibodies, by Region, Through 2028
Table 34: Global Market for Other Research Antibodies, by Region, Through 2028
Table 35: Global Market for Research Antibodies, by End User, Through 2028
Table 36: Global Market for Research Antibodies Used by Universities and Academic Institutions, by Region, Through 2028
Table 37: Global Market for Research Antibodies Used by Pharma and Biotech Companies, by Region, Through 2028
Table 38: Global Market for Research Antibodies Used by Other End Users, by Region, Through 2028
Table 39: Global Market for Research Antibodies, by Region, Through 2028
Table 40: U.S. Grants for Research, by Type of Cancer, 2023
Table 41: North American Market for Research Antibodies, by Country, Through 2028
Table 42: U.S. Market for Research Antibodies, by Type of Antibody, Through 2028
Table 43: U.S. Market for Research Antibodies, by Clonality, Through 2028
Table 44: U.S. Market for Research Antibodies, by Major Reactivity, Through 2028
Table 45: U.S. Market for Research Antibodies, by Application, Through 2028
Table 46: U.S. Market for Research Antibodies, by Host Species, Through 2028
Table 47: U.S. Market for Research Antibodies, by End User, Through 2028
Table 48: Canadian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 49: Canadian Market for Research Antibodies, by Clonality, Through 2028
Table 50: Canadian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 51: Canadian Market for Research Antibodies, by Application, Through 2028
Table 52: Canadian Market for Research Antibodies, by Host Species, Through 2028
Table 53: Canadian Market for Research Antibodies, by End User, Through 2028
Table 54: Estimated Top New Cancer Cases in Canada, 2022
Table 55: Mexican Market for Research Antibodies, by Type of Antibody, Through 2028
Table 56: Mexican Market for Research Antibodies, by Clonality, Through 2028
Table 57: Mexican Market for Research Antibodies, by Major Reactivity, Through 2028
Table 58: Mexican Market for Research Antibodies, by Application, Through 2028
Table 59: Mexican Market for Research Antibodies, by Host Species, Through 2028
Table 60: Mexican Market for Research Antibodies, by End User, Through 2028
Table 61: European Market for Research Antibodies, by Country, Through 2028
Table 62: German Market for Research Antibodies, by Type of Antibody, Through 2028
Table 63: German Market for Research Antibodies, by Clonality, Through 2028
Table 64: German Market for Research Antibodies, by Major Reactivity, Through 2028
Table 65: German Market for Research Antibodies, by Application, Through 2028
Table 66: German Market for Research Antibodies, by Host Species, Through 2028
Table 67: German Market for Research Antibodies, by End User, Through 2028
Table 68: French Market for Research Antibodies, by Type of Antibody, Through 2028
Table 69: French Market for Research Antibodies, by Clonality, Through 2028
Table 70: French Market for Research Antibodies, by Major Reactivity, Through 2028
Table 71: French Market for Research Antibodies, by Application, Through 2028
Table 72: French Market for Research Antibodies, by Host Species, Through 2028
Table 73: French Market for Research Antibodies, by End User, Through 2028
Table 74: U.K. Market for Research Antibodies, by Type of Antibody, Through 2028
Table 75: U.K. Market for Research Antibodies, by Clonality, Through 2028
Table 76: U.K. Market for Research Antibodies, by Major Reactivity, Through 2028
Table 77: U.K. Market for Research Antibodies, by Application, Through 2028
Table 78: U.K. Market for Research Antibodies, by Host Species, Through 2028
Table 79: U.K. Market for Research Antibodies, by End User, Through 2028
Table 80: Italian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 81: Italian Market for Research Antibodies, by Clonality, Through 2028
Table 82: Italian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 83: Italian Market for Research Antibodies, by Application, Through 2028
Table 84: Italian Market for Research Antibodies, by Host Species, Through 2028
Table 85: Italian Market for Research Antibodies, by End User, Through 2028
Table 86: Spanish Market for Research Antibodies, by Type of Antibody, Through 2028
Table 87: Spanish Market for Research Antibodies, by Clonality, Through 2028
Table 88: Spanish Market for Research Antibodies, by Major Reactivity, Through 2028
Table 89: Spanish Market for Research Antibodies, by Application, Through 2028
Table 90: Spanish Market for Research Antibodies, by Host Species, Through 2028
Table 91: Spanish Market for Research Antibodies, by End User, Through 2028
Table 92: Rest of European Market for Research Antibodies, by Type of Antibody, Through 2028
Table 93: Rest of European Market for Research Antibodies, by Clonality, Through 2028
Table 94: Rest of European Market for Research Antibodies, by Major Reactivity, Through 2028
Table 95: Rest of European Market for Research Antibodies, by Application, Through 2028
Table 96: Rest of European Market for Research Antibodies, by Host Species, Through 2028
Table 97: Rest of European Market for Research Antibodies, by End User, Through 2028
Table 98: Asia-Pacific Market for Research Antibodies, by Country, Through 2028
Table 99: Japanese Market for Research Antibodies, by Type of Antibody, Through 2028
Table 100: Japanese Market for Research Antibodies, by Clonality, Through 2028
Table 101: Japanese Market for Research Antibodies, by Major Reactivity, Through 2028
Table 102: Japanese Market for Research Antibodies, by Application, Through 2028
Table 103: Japanese Market for Research Antibodies, by Host Species, Through 2028
Table 104: Japanese Market for Research Antibodies, by End User, Through 2028
Table 105: Top Five Research Institutions in Japan in Antibody Use,2022
Table 106: Chinese Market for Research Antibodies, by Type of Antibody, Through 2028
Table 107: Chinese Market for Research Antibodies, by Clonality, Through 2028
Table 108: Chinese Market for Research Antibodies, by Major Reactivity, Through 2028
Table 109: Chinese Market for Research Antibodies, by Application, Through 2028
Table 110: Chinese Market for Research Antibodies, by Host Species, Through 2028
Table 111: Chinese Market for Research Antibodies, by End User, Through 2028
Table 112: Indian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 113: Indian Market for Research Antibodies, by Clonality, Through 2028
Table 114: Indian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 115: Indian Market for Research Antibodies, by Application, Through 2028
Table 116: Indian Market for Research Antibodies, by Host Species, Through 2028
Table 117: Indian Market for Research Antibodies, by End User, Through 2028
Table 118: Australian and New Zealand Market for Research Antibodies, by Type of Antibody, Through 2028
Table 119: Australian and New Zealand Market for Research Antibodies, by Clonality, Through 2028
Table 120: Australian and New Zealand Market for Research Antibodies, by Major Reactivity, Through 2028
Table 121: Australian and New Zealand Market for Research Antibodies, by Application, Through 2028
Table 122: Australian and New Zealand Market for Research Antibodies, by Host Species, Through 2028
Table 123: Australian and New Zealand Market for Research Antibodies, by End User, Through 2028
Table 124: Rest of Asia-Pacific Market for Research Antibodies, by Type of Antibody, Through 2028
Table 125: Rest of Asia-Pacific Market for Research Antibodies, by Clonality, Through 2028
Table 126: Rest of Asia-Pacific Market for Research Antibodies, by Major Reactivity, Through 2028
Table 127: Rest of Asia-Pacific Market for Research Antibodies, by Application, Through 2028
Table 128: Rest of Asia-Pacific Market for Research Antibodies, by Host Species, Through 2028
Table 129: Rest of Asia-Pacific Market for Research Antibodies, by End User, Through 2028
Table 130: Rest of World Market for Research Antibodies, by Country/Region, Through 2028
Table 131: Brazilian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 132: Brazilian Market for Research Antibodies, by Clonality, Through 2028
Table 133: Brazilian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 134: Brazilian Market for Research Antibodies, by Application, Through 2028
Table 135: Brazilian Market for Research Antibodies, by Host Species, Through 2028
Table 136: Brazilian Market for Research Antibodies, by End User, Through 2028
Table 137: GCC countries Market for Research Antibodies, by Type of Antibody, Through 2028
Table 138: GCC Countries Market for Research Antibodies, by Clonality, Through 2028
Table 139: GCC Countries Market for Research Antibodies, by Major Reactivity, Through 2028
Table 140: GCC Countries Market for Research Antibodies, by Application, Through 2028
Table 141: GCC Countries Market for Research Antibodies, by Host Species, Through 2028
Table 142: GCC Countries Market for Research Antibodies, by End User, Through 2028
Table 143: Rest of World Countries Market for Research Antibodies, by Type of Antibody, Through 2028
Table 144: Rest of World Countries Market for Research Antibodies, by Clonality, Through 2028
Table 145: Rest of World Countries Market for Research Antibodies, by Major Reactivity, Through 2028
Table 146: Rest of World Countries Market for Research Antibodies, by Application, Through 2028
Table 147: Rest of World Countries Market for Research Antibodies, by Host Species, Through 2028
Table 148: Rest of World Countries Market for Research Antibodies, by End User, Through 2028
Table 149: Environmental, Social and Governance Ratings and Metrics
Table 150: Environmental, Social and Governance Practices: Environmental Performance
Table 151: Environmental, Social and Governance Practices: Social Performance
Table 152: Environmental, Social and Governance Practices: Governance Performance
Table 153: Recent Awards to Major Companies
Table 154: Environmental, Social and Governance Rankings for Major Research Antibodies Companies, 2023*
Table 155: Emerging Trends
Table 156: Antibody Structure Modeling Methods
Table 157: Current Computational Databases and Tools for Analysis and Prediction of Antibody Structure, Sequence and Properties
Table 158: FDA-Approved Monoclonal Antibodies in the Market
Table 159: Regional Distribution of Manufacturing Capacity, by Mammalian Cell Culture Capacity, 2002-2022
Table 160: Regional Distribution of Manufacturing Capacity, by Noninsulin Microbial Capacity, 2002-2022
Table 161: Abcam Plc: Company Snapshot
Table 162: Abcam plc: Product Portfolio
Table 163: Absolute Antibody Ltd.: Product Portfolio
Table 164: Agilent Technologies: Company Snapshot
Table 165: Agilent Technologies Inc.: Product Portfolio
Table 166: BD Biosciences: Company Snapshot
Table 167: BD Biosciences: Product Portfolio
Table 168: Bio-Rad: Company Snapshot
Table 169: Bio-Rad: Product Portfolio
Table 170: Bio-Techne: Company Snapshot
Table 171: Bio-Techne: Product Portfolio
Table 172: Cell Signaling Technology Inc.: Product Portfolio, by Type
Table 173: Cell Signaling Technology Inc.: Products Portfolio, by Source
Table 174: Danaher: Company Snapshot
Table 175: Danaher (Beckman Coulter Inc.): Product Portfolio
Table 176: Jackson ImmunoResearch Laboratories: Product Portfolio
Table 177: Lonza: Company Snapshot
Table 178: Lonza: Product Portfolio
Table 179: Merck KGAA (Sigma-Millipore): Company Snapshot
Table 180: Merck KGAA (Sigma-Millipore): Product Portfolio
Table 181: Rockland Immunochemical Inc.: Product Portfolio
Table 182: Santa Cruz Biotechnology Inc.: Product Portfolio
Table 183: Sino Biological Inc.: Company Snapshot
Table 184: Sino Biological Inc.: Product Portfolio
Table 185: Thermo Fisher Scientific Inc.: Company Snapshot
Table 186: Thermo Fisher Scientific Inc.: Product Portfolio
Table 187: United States Biological: Product Portfolio
Table 188: United States Biological: Product Portfolio Description
Table 189: Acronyms Used in This Report

Summary Figure: Global Market Shares of Research Antibodies, by Application, 2022
Figure:
Figure 1: Global Markets for Research Antibodies Market Dynamics
Figure 2: Global Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 3: Global Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 4: Global Market for Primary Antibodies, 2020-2028
Figure 5: Global Market for Primary Antibodies, by Region, 2020-2028
Figure 6: Global Market for Secondary Antibodies, 2020-2028
Figure 7: Global Market for Secondary Antibodies, by Region, 2020-2028
Figure 8: Global Market Shares of Research Antibodies, by Clonality, 2022
Figure 9: Global Market Shares of Research Antibodies, by Clonality, 2028
Figure 10: Global Market for Polyclonal Antibodies, 2020-2028
Figure 11: Global Market for Polyclonal Antibodies, by Region, 2020-2028
Figure 12: Global Market for Monoclonal Antibodies, 2020-2028
Figure 13: Global Market for Monoclonal Antibodies, by Region, 2020-2028
Figure 14: Global Market for Recombinant Antibodies, 2020-2028
Figure 15: Global Market for Recombinant Antibodies, by Region, 2020-2028
Figure 16: Global Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 17: Global Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 18: Global Market for Anti-Human Antibodies, 2020-2028
Figure 19: Global Market for Anti-Human Antibodies, by Region, 2020-2028
Figure 20: Global Market for Anti-Mouse Antibodies, 2020-2028
Figure 21: Global Market for Anti-Mouse Antibodies, by Region, 2020-2028
Figure 22: Global Market for Anti-Rat Antibodies, 2020-2028
Figure 23: Global Market for Anti-Rat Antibodies, by Region, 2020-2028
Figure 24: Global Market for Other Research Antibodies, 2020-2028
Figure 25: Global Market for Other Research Antibodies, by Region, 2020-2028
Figure 26: Global Market Shares of Research Antibodies, by Application, 2022
Figure 27: Global Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 28: Global Market Shares of Research Antibodies, by Application, 2028
Figure 29: Global Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 30: Global Market for Western Blot Applications, 2020-2028
Figure 31: Global Market for Western Blot Applications, by Region, 2020-2028
Figure 32: Global Market for Flow Cytometry Applications, 2020-2028
Figure 33: Global Market for Flow Cytometry Applications, by Region, 2020-2028
Figure 34: Estimated New Cases of Leukemia, Lymphoma and Myeloma, 2020
Figure 35: Global Market for Immunohistochemistry Applications, 2020-2028
Figure 36: Global Market for Immunohistochemistry Applications, by Region, 2020-2028
Figure 37: Global Market for Multiplex Staining Applications, 2020-2028
Figure 38: Global Market for Multiplex Staining Applications, by Region, 2020-2028
Figure 39: Global Market for Low-Flexed Staining Applications, 2020-2028
Figure 40: Global Market for Low-Flexed Staining Applications, by Region, 2020-2028
Figure 41: Global Market for Immunocytochemistry Applications, 2020-2028
Figure 42: Global Market for Immunocytochemistry Applications, by Region, 2020-2028
Figure 43: Global Market for Immunofluorescent Applications, 2020-2028
Figure 44: Global Market for Immunofluorescent Applications, by Region, 2020-2028
Figure 45: Global Market for Immunoprecipitation Applications, 2020-2028
Figure 46: Global Market for Immunoprecipitation Applications, by Region, 2020-2028
Figure 47: Global Market for ELISA Applications, 2020-2028
Figure 48: Global Market for ELISA Applications, by Region, 2020-2028
Figure 49: Global Market Shares of Research Antibodies, by Host Species, 2022
Figure 50: Global Market Shares of Research Antibodies, by Host Species, 2028
Figure 51: Rabbits Used in Research, Testing and Teaching in the U.S., 2012-2021
Figure 52: Global Market for Rabbit Research Antibodies, 2020-2028
Figure 53: Global Market for Rabbit Research Antibodies, by Region, 2020-2028
Figure 54: Global Market for Goat Research Antibodies, 2020-2028
Figure 55: Global Market for Goat Research Antibodies, by Region, 2020-2028
Figure 56: Global Market for Mouse Research Antibodies, 2020-2028
Figure 57: Global Market for Mouse Research Antibodies, by Region, 2020-2028
Figure 58: Antigen-Antibody Interaction Between Mouse mAb and Four Human Enterovirus
Figure 59: Global Market for Sheep Research Antibodies, 2020-2028
Figure 60: Global Market for Sheep Research Antibodies, by Region, 2020-2028
Figure 61: Global Market for Donkey Research Antibodies, 2020-2028
Figure 62: Global Market for Donkey Research Antibodies, by Region, 2020-2028
Figure 63: Global Market for Other Research Antibodies, 2020-2028
Figure 64: Global Market for Other Research Antibodies, by Region, 2020-2028
Figure 65: Global Market Shares of Research Antibodies, by End User, 2022
Figure 66: Global Market Shares of Research Antibodies, by End User, 2028
Figure 67: Global Incidence of Patients with Chronic Diseases, 2005-2030
Figure 68: Global Market for Research Antibodies Used by Universities and Academic Institutions, 2020-2028
Figure 69: Global Market for Research Antibodies Used by Universities and Academic Institutions, by Region, 2020-2028
Figure 70: Global Market for Research Antibodies Used by Pharma and Biotech Companies, 2020-2028
Figure 71: Global Market for Research Antibodies Used by Pharma and Biotech Companies, by Region, 2020-2028
Figure 72: Global Market for Research Antibodies Used by Other End Users, 2020-2028
Figure 73: Global Market for Research Antibodies Used by Other End Users, by Region, 2020-2028
Figure 74: Global Market Shares of Research Antibodies, by Region, 2022
Figure 75: Global Market Shares of Research Antibodies, by Region, 2028
Figure 76: People Aged 65 Years or Older with Alzheimer’s Dementia in the U.S., 2023
Figure 77: Alzheimer’s Disease Facts, 2023
Figure 78: North American Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 79: North American Market Shares of Research Antibodies, by Clonality, 2022
Figure 80: North American Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 81: North American Market Shares of Research Antibodies, by Application, 2022
Figure 82: North American Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 83: North American Market Shares of Research Antibodies, by Host Species, 2022
Figure 84: North American Market Shares of Research Antibodies, by End User, 2022
Figure 85: North American Market Shares of Research Antibodies, by Country, 2022
Figure 86: U.S. Market for Research Antibodies, 2020-2028
Figure 87: U.S. Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 88: U.S. Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 89: U.S. Market Shares of Research Antibodies, by Clonality, 2022
Figure 90: U.S. Market Shares of Research Antibodies, by Clonality, 2028
Figure 91: U.S. Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 92: U.S. Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 93: U.S. Market Shares of Research Antibodies, by Application, 2022
Figure 94: U.S. Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 95: U.S. Market Shares of Research Antibodies, by Application, 2028
Figure 96: U.S. Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 97: U.S. Market Shares of Research Antibodies, by Host Species, 2022
Figure 98: U.S. Market Shares of Research Antibodies, by Host Species, 2028
Figure 99: U.S. Market Shares of Research Antibodies, by End User, 2022
Figure 100: U.S. Market Shares of Research Antibodies, by End User, 2028
Figure 101: Canadian Market for Research Antibodies, 2020-2028
Figure 102: Canadian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 103: Canadian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 104: Canadian Market Shares of Research Antibodies, by Clonality, 2022
Figure 105: Canadian Market Shares of Research Antibodies, by Clonality, 2028
Figure 106: Canadian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 107: Canadian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 108: Canadian Market Shares of Research Antibodies, by Application, 2022
Figure 109: Canadian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 110: Canadian Market Shares of Research Antibodies, by Application, 2028
Figure 111: Canadian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 112: Canadian Market Shares of Research Antibodies, by Host Species, 2022
Figure 113: Canadian Market Shares of Research Antibodies, by Host Species, 2028
Figure 114: Canadian Market Shares of Research Antibodies, by End User, 2022
Figure 115: Canadian Market Shares of Research Antibodies, by End User, 2028
Figure 116: Mexican Market for Research Antibodies, 2020-2028
Figure 117: Mexican Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 118: Mexican Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 119: Mexican Market Shares of Research Antibodies, by Clonality, 2022
Figure 120: Mexican Market Shares of Research Antibodies, by Clonality, 2028
Figure 121: Mexican Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 122: Mexican Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 123: Mexican Market Shares of Research Antibodies, by Application, 2022
Figure 124: Mexican Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 125: Mexican Market Shares of Research Antibodies, by Application, 2028
Figure 126: Mexican Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 127: Mexican Market Shares of Research Antibodies, by Host Species, 2022
Figure 128: Mexican Market Shares of Research Antibodies, by Host Species, 2028
Figure 129: Mexican Market Shares of Research Antibodies, by End User, 2022
Figure 130: Mexican Market Shares of Research Antibodies, by End User, 2028
Figure 131: European Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 132: European Market Shares of Research Antibodies, by Clonality, 2022
Figure 133: European Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 134: European Market Shares of Research Antibodies, by Application, 2022
Figure 135: European Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 136: European Market Shares of Research Antibodies, by Host Species, 2022
Figure 137: European Market Shares of Research Antibodies, by End User, 2022
Figure 138: European Market Shares of Research Antibodies, by Country, 2022
Figure 139: German Market for Research Antibodies, 2020-2028
Figure 140: German Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 141: German Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 142: German Market Shares of Research Antibodies, by Clonality, 2022
Figure 143: German Market Shares of Research Antibodies, by Clonality, 2028
Figure 144: German Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 145: German Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 146: German Market Shares of Research Antibodies, by Application, 2022
Figure 147: German Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 148: German Market Shares of Research Antibodies, by Application, 2028
Figure 149: German Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 150: German Market Shares of Research Antibodies, by Host Species, 2022
Figure 151: German Market Shares of Research Antibodies, by Host Species, 2028
Figure 152: German Market Shares of Research Antibodies, by End User, 2022
Figure 153: German Market Shares of Research Antibodies, by End User, 2028
Figure 154: German Global Health Spending, by Subsector, 2021
Figure 155: German Global Health Spending, 2021
Figure 156: French Market for Research Antibodies, 2020-2028
Figure 157: French Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 158: French Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 159: French Market Shares of Research Antibodies, by Clonality, 2022
Figure 160: French Market Shares of Research Antibodies, by Clonality, 2028
Figure 161: French Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 162: French Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 163: French Market Shares of Research Antibodies, by Application, 2022
Figure 164: French Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 165: French Market Shares of Research Antibodies, by Application, 2028
Figure 166: French Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 167: French Market Shares of Research Antibodies, by Host Species, 2022
Figure 168: French Market Shares of Research Antibodies, by Host Species, 2028
Figure 169: French Market Shares for Research Antibodies, by End User, 2022
Figure 170: French Market Shares of Research Antibodies, by End User, 2028
Figure 171: France Expected Diagnosed Cancer for Women, 2020
Figure 172: France Expected Diagnosed Cancer for Men, 2020
Figure 173: French Health Spending and Financing, 2015-2020
Figure 174: U.K. Market for Research Antibodies, 2020-2028
Figure 175: U.K. Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 176: U.K. Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 177: U.K. Market Shares of Research Antibodies, by Clonality, 2022
Figure 178: U.K. Market Shares of Research Antibodies, by Clonality, 2028
Figure 179: U.K. Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 180: U.K. Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 181: U.K. Market Shares of Research Antibodies, by Application, 2022
Figure 182: U.K. Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 183: U.K. Market Shares of Research Antibodies, by Application, 2028
Figure 184: U.K. Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 185: U.K. Market Shares of Research Antibodies, by Host Species, 2022
Figure 186: U.K. Market Shares of Research Antibodies, by Host Species, 2028
Figure 187: U.K. Market Shares of Research Antibodies, by End User, 2022
Figure 188: U.K. Market Shares of Research Antibodies, by End User, 2028
Figure 189: Italian Market for Research Antibodies, 2020-2028
Figure 190: Italian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 191: Italian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 192: Italian Market Shares of Research Antibodies, by Clonality, 2022
Figure 193: Italian Market Shares of Research Antibodies, by Clonality, 2028
Figure 194: Italian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 195: Italian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 196: Italian Market Shares of Research Antibodies, by Application, 2022
Figure 197: Italian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 198: Italian Market Shares of Research Antibodies, by Application, 2028
Figure 199: Italian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 200: Italian Market Shares of Research Antibodies, by Host Species, 2022
Figure 201: Italian Market Shares of Research Antibodies, by Host Species, 2028
Figure 202: Italian Market Shares of Research Antibodies, by End User, 2022
Figure 203: Italian Market Shares of Research Antibodies, by End User, 2028
Figure 204: Leading Subsectors in Italy, 2020
Figure 205: Spanish Market for Research Antibodies, 2020-2028
Figure 206: Spanish Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 207: Spanish Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 208: Spanish Market Shares of Research Antibodies, by Clonality, 2022
Figure 209: Spanish Market Shares of Research Antibodies, by Clonality, 2028
Figure 210: Spanish Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 211: Spanish Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 212: Spanish Market Shares of Research Antibodies, by Application, 2022
Figure 213: Spanish Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 214: Spanish Market Shares of Research Antibodies, by Application, 2028
Figure 215: Spanish Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 216: Spanish Market Shares of Research Antibodies, by Host Species, 2022
Figure 217: Spanish Market Shares of Research Antibodies, by Host Species, 2028
Figure 218: Spanish Market Shares of Research Antibodies, by End User, 2022
Figure 219: Spanish Market Shares of Research Antibodies, by End User, 2028
Figure 220: Rest of European Market for Research Antibodies, 2020-2028
Figure 221: Rest of European Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 222: Rest of European Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 223: Rest of European Market Shares of Research Antibodies, by Clonality, 2022
Figure 224: Rest of European Market Shares of Research Antibodies, by Clonality, 2028
Figure 225: Rest of European Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 226: Rest of European Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 227: Rest of European Market Shares of Research Antibodies, by Application, 2022
Figure 228: Rest of European Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 229: Rest of European Market Shares of Research Antibodies, by Application, 2028
Figure 230: Rest of European Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 231: Rest of European Market Shares of Research Antibodies, by Host Species, 2022
Figure 232: Rest of European Market Shares of Research Antibodies, by Host Species, 2028
Figure 233: Rest of European Market Shares of Research Antibodies, by End User, 2022
Figure 234: Rest of European Market Shares of Research Antibodies, by End User, 2028
Figure 235: Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 236: Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2022
Figure 237: Asia-Pacific Market Shares of Research Antibodies Market, by Major Reactivity, 2022
Figure 238: Asia-Pacific Market Shares of Research Antibodies, by Application, 2022
Figure 239: Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 240: Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2022
Figure 241: Asia-Pacific Market Shares of Research Antibodies, by End User, 2022
Figure 242: Regional Growth in Multi-specific Monoclonal Antibodies, by Region, 2018-2022
Figure 243: Asia-Pacific Market Shares of Research Antibodies, by Country, 2022
Figure 244: Japanese Market for Research Antibodies, 2020-2028
Figure 245: Japanese Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 246: Japanese Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 247: Japanese Market Shares of Research Antibodies, by Clonality, 2022
Figure 248: Japanese Market Shares of Research Antibodies, by Clonality, 2028
Figure 249: Japanese Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 250: Japanese Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 251: Japanese Market Shares of Research Antibodies, by Application, 2022
Figure 252: Japanese Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 253: Japanese Market Shares of Research Antibodies, by Application, 2028
Figure 254: Japanese Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 255: Japanese Market Shares of Research Antibodies, by Host Species, 2022
Figure 256: Japanese Market Shares of Research Antibodies, by Host Species, 2028
Figure 257: Japanese Market Shares of Research Antibodies, by End User, 2022
Figure 258: Japanese Market Shares of Research Antibodies, by End User, 2028
Figure 259: Top Five Antibody Suppliers Shares in Japan, 2021
Figure 260: Chinese Market for Research Antibodies, 2020-2028
Figure 261: Chinese Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 262: Chinese Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 263: Chinese Market Shares of Research Antibodies, by Clonality, 2022
Figure 264: Chinese Market Shares of Research Antibodies, by Clonality, 2028
Figure 265: Chinese Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 266: Chinese Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 267: Chinese Market Shares of Research Antibodies, by Application, 2022
Figure 268: Chinese Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 269: Chinese Market Shares of Research Antibodies, by Application, 2028
Figure 270: Chinese Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 271: Chinese Market Shares of Research Antibodies, by Host Species, 2022
Figure 272: Chinese Market Shares of Research Antibodies, by Host Species, 2028
Figure 273: Chinese Market Shares of Research Antibodies, by End User, 2022
Figure 274: Chinese Market Shares of Research Antibodies, by End User, 2028
Figure 275: Chinese Market Growth Challenges, 2023
Figure 276: Indian Market for Research Antibodies, 2020-2028
Figure 277: Indian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 278: Indian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 279: Indian Market Shares of Research Antibodies, by Clonality, 2022
Figure 280: Indian Market Shares of Research Antibodies, by Clonality, 2028
Figure 281: Indian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 282: Indian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 283: Indian Market Shares of Research Antibodies, by Application, 2022
Figure 284: Indian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 285: Indian Market Shares of Research Antibodies, by Application, 2028
Figure 286: Indian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 287: Indian Market Shares of Research Antibodies, by Host Species, 2022
Figure 288: Indian Market Shares of Research Antibodies, by Host Species, 2028
Figure 289: Indian Market Shares of Research Antibodies, by End User, 2022
Figure 290: Indian Market Shares of Research Antibodies, by End User, 2028
Figure 291: Indian Market of Bioeconomy, 2021
Figure 292: Indian Market of Bioeconomy’s Key Subsegment, 2021
Figure 293: Australian and New Zealand Market for Research Antibodies, 2020-2028
Figure 294: Australian and New Zealand Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 295: Australian and New Zealand Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 296: Australian and New Zealand Market Shares of Research Antibodies, by Clonality, 2022
Figure 297: Australian and New Zealand Market Shares of Research Antibodies, by Clonality, 2028
Figure 298: Australian and New Zealand Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 299: Australian and New Zealand Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 300: Australian and New Zealand Market Shares of Research Antibodies, by Application, 2022
Figure 301: Australian and New Zealand Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 302: Australian and New Zealand Market Shares of Research Antibodies, by Application, 2028
Figure 303: Australian and New Zealand Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 304: Australian and New Zealand Market Shares of Research Antibodies, by Host Species, 2022
Figure 305: Australian and New Zealand Market Shares of Research Antibodies, by Host Species, 2028
Figure 306: Australian and New Zealand Market Shares of Research Antibodies, by End User, 2022
Figure 307: Australian and New Zealand Market Shares of Research Antibodies, by End User, 2028
Figure 308: Australian and New Zealand Market Shares of Research Antibodies, by End User, 2028
Figure 309: Rest of Asia-Pacific Market for Research Antibodies, 2020-2028
Figure 310: Rest of Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 311: Rest of Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 312: Rest of Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2022
Figure 313: Rest of Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2028
Figure 314: Rest of Asia-Pacific Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 315: Rest of Asia-Pacific Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 316: Rest of Asia-Pacific Market Shares of Research Antibodies, by Application, 2022
Figure 317: Rest of Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 318: Rest of Asia-Pacific Shares of Research Antibodies, by Application, 2028
Figure 319: Rest of Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 320: Rest of Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2022
Figure 321: Rest of Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2028
Figure 322: Rest of Asia-Pacific Market Shares of Research Antibodies, by End User, 2022
Figure 323: Rest of Asia-Pacific Market Shares of Research Antibodies, by End User, 2028
Figure 324: Rest of World Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 325: Rest of World Market Shares of Research Antibodies, by Clonality, 2022
Figure 326: Rest of World Market Shares of Research Antibodies Market, by Major Reactivity, 2022
Figure 327: Rest of World Market Shares of Research Antibodies, by Application, 2022
Figure 328: Rest of World Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 329: Rest of World Market Shares of Research Antibodies, by Host Species, 2022
Figure 330: Rest of World Market Shares of Research Antibodies, by End User, 2022
Figure 331: Rest of the World Market Shares of Research Antibodies, by Country/Region, 2022
Figure 332: Brazilian Market for Research Antibodies, 2020-2028
Figure 333: Brazilian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 334: Brazilian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 335: Brazilian Market Shares of Research Antibodies, by Clonality, 2022
Figure 336: Brazilian Market Shares of Research Antibodies, by Clonality, 2028
Figure 337: Brazilian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 338: Brazilian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 339: Brazilian Market Shares of Research Antibodies, by Application, 2022
Figure 340: Brazilian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 341: Brazilian Market Shares of Research Antibodies, by Application, 2028
Figure 342: Brazilian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 343: Brazilian Market Shares of Research Antibodies, by Host Species, 2022
Figure 344: Brazilian Market Shares of Research Antibodies, by Host Species, 2028
Figure 345: Brazilian Market Shares of Research Antibodies, by End User, 2022
Figure 346: Brazilian Market Shares of Research Antibodies, by End User, 2028
Figure 347: GCC Countries Market for Research Antibodies, 2020-2028
Figure 348: GCC countries Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 349: GCC Countries Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 350: GCC Countries Market Shares of Research Antibodies, by Clonality, 2022
Figure 351: GCC Countries Market Shares of Research Antibodies, by Clonality, 2028
Figure 352: GCC Countries Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 353: GCC Countries Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 354: GCC countries Market Shares of Research Antibodies, by Application, 2022
Figure 355: GCC Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 356: GCC Countries Market Shares of Research Antibodies, by Application, 2028
Figure 357: GCC Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 358: GCC Countries Market Shares of Research Antibodies, by Host Species, 2022
Figure 359: GCC Countries Market Shares of Research Antibodies, by Host Species, 2028
Figure 360: GCC Countries Market Shares of Research Antibodies, by End User, 2022
Figure 361: GCC Countries Market Shares of Research Antibodies, by End User, 2028
Figure 362: Rest of World Countries Market for Research Antibodies, 2020-2028
Figure 363: Rest of World Countries Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 364: Rest of World Countries Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 365: Rest of World Countries Market Shares of Research Antibodies, by Clonality, 2022
Figure 366: Rest of World Countries Market Shares of Research Antibodies, by Clonality, 2028
Figure 367: Rest of World Countries Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 368: Rest of World Countries Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 369: Rest of World Countries Market Shares of Research Antibodies, by Application, 2022
Figure 370: Rest of World Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 371: Rest of World Countries Market Shares of Research Antibodies, by Application, 2028
Figure 372: Rest of World Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 373: Rest of World Countries Market Shares of Research Antibodies, by Host Species, 2022
Figure 374: Rest of World Countries Market Shares of Research Antibodies, by Host Species, 2028
Figure 375: Rest of World Countries Market Shares of Research Antibodies, by End User, 2022
Figure 376: Rest of World Countries Market Shares of Research Antibodies, by End User, 2028
Figure 377: U.S. versus the Rest of the World Market Shares of Monoclonal Antibodies, 2021
Figure 378: Snapshot: Key Environmental, Social and Governance Trends in the Research Antibodies Industry
Figure 379: Snapshot: Key Environmental, Social and Governance Trends in the Research Antibodies Industry
Figure 380: Merck’s ESG Priorities Matrix, 2022
Figure 381: Bio-Rad ESG Priorities Matrix, 2022
Figure 382: Schematic Illustration of Traditional Strategies for Antibody Discovery and Generation
Figure 383: Schematic Illustration of Emerging Strategies for Antibody Discovery and Generation
Figure 384: Snapshot: Key Trends in the Growth of Antibody Production Technologies
Figure 385: Classification of Soft Computing Approaches
Figure 386: Global Market Ranking of Manufacturers of Research Antibodies, 2022
Figure 387: Distribution of Anti-SARS-CoV-2 Immunoglobulin
Figure 388: Top 100 Antibodies, 2022
Figure 389: Abcam plc.: Annual Revenue, 2020-2022
Figure 390: Abcam plc.: Revenue Shares, by Region, 2022
Figure 391: Abcam plc.: Revenue Shares, by Business Segment, 2022
Figure 392: Agilent Technologies Inc.: Annual Revenue, 2016-2022
Figure 393: Agilent Technologies Inc.: Revenue Shares, by Region, 2022
Figure 394: Agilent Technologies Inc.: Revenue Shares, by Business Segment, 2022
Figure 395: BD Biosciences: Annual Revenue, 2019-2022
Figure 396: BD Biosciences: Revenue Shares, by Region, 2022
Figure 397: BD Biosciences: Revenue Shares, by Business Segments, 2022
Figure 398: Bio-Rad: Annual Revenue, 2019-2022
Figure 399: Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, 2022
Figure 400: Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, 2022
Figure 401: Bio-Techne: Annual Revenue, 2016-2022